$0.93
▼ -10.7% Today
as of Oct 22, 16:46 ET
Last 30 days
Recent Press Releases & News
BioCardia Announces FDA Acceptance of De Novo Pre-Submission Package for Helix™ Catheter Marketing Clearance FDA Substantive Review and Meeting Expected this Quarter
BioCardia Presents CardiAMP HF II Trial Design at Heart Failure Society of America Annual Scientific Meeting
BioCardia Files Revised De Novo Pre-Submission for FDA Approval of Helix™ Catheter
BCDA earnings at a glance
Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±4.2% on average; after the most recent report on May 15, 2026 it moved -7.3%. BCDA beat the consensus EPS estimate in 1 of its last 2 reported quarters. The share price of $0.93 sits near its 52-week low.
Overview
52-week range
$0.75
$1.80
17% of range
Avg surprise (last 2)
-9.8%
Avg reaction (last 2)
-3.1%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Fri May 15, 2026 | Mar/2026 | $-0.21 | $-0.17 | -23.5% | +64.4% | -7.3% | earnings |
| Wed Nov 12, 2025 | Sep/2025 | $-0.24 | $-0.25 | +4.0% | — | — | earnings |
| Mon Aug 11, 2025 | Jun/2025 | $-0.40 | — | — | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $-0.59 | — | — | — | +1.1% | earnings |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0 | $0 | $0 | — | $0 |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-2M | $-2M | — | $-1M | $-2M | $-3M | — | $-2M |
| Net income | $-2M | $-2M | — | $-1M | $-2M | $-3M | — | $-2M |
| EPS (diluted) | — | $-0.21 | — | — | $-0.40 | $-0.59 | — | — |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $4M | $951,000 | $2M | $5M | $980,000 | $949,000 | $2M | $5M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $4M | $1M | $3M | $5M | $1M | $1M | $3M | $5M |
| Total assets | $5M | $2M | $3M | $6M | $2M | $2M | $4M | $6M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $2M | $3M | $3M | $4M | $4M | $4M | $3M | $4M |
| Total equity | $3M | $-1M | $895,000 | $3M | $-2M | $-2M | $837,000 | $3M |
Implied volatility — last 90 days
No IV snapshots yet for BCDA.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
BCDA earnings FAQ
How does BCDA stock usually react to earnings?
Across the last 2 reports the average next-day move was ±4.2%, up 1 times and down 1 times.